Literature DB >> 28512507

Homonymous Hemianopsia Due to Posterior Cortical Atrophy.

Francesco Pellegrini1, Andrew G Lee2,3,4,5,6,7,8,9, Pietro Zucchetta10.   

Abstract

A 63-year-old woman presented to her ophthalmologist complaining of reading difficulties for two years. Ophthalmological examination revealed a homonymous hemianopsia. Brain magnetic resonance imaging (MRI) scan was interpreted as normal, but positron emission tomography (PET) showed areas of posterior brain hypometabolism. This case highlights the high diagnostic suspicion that ophthalmologists should have regarding posterior cortical atrophy (including the visual variant of Alzheimer disease) in patients complaining of reading difficulties in the setting of a normal ophthalmic examination.

Entities:  

Keywords:  Brain PET; homonymous hemianopsia; posterior cortical atrophy; visual variant of Alzheimer disease

Year:  2017        PMID： 28512507      PMCID： PMC5417079          DOI： 10.1080/01658107.2016.1278556

Source DB:  PubMed          Journal:  Neuroophthalmology        ISSN： 0165-8107


  26 in total

1.  Posterior cortical atrophy.

Authors:  K K Zakzanis; M I Boulos
Journal:  Neurologist       Date:  2001-11       Impact factor: 1.398

2.  Homonymous visual field defects in patients without corresponding structural lesions on neuroimaging.

Authors:  P W Brazis; A G Lee; N Graff-Radford; N P Desai; E R Eggenberger
Journal:  J Neuroophthalmol       Date:  2000-06       Impact factor: 3.042

3.  Posterior cortical atrophy: variant of Alzheimer's disease? A case series with PET findings.

Authors:  Klaus Schmidtke; Michael Hüll; Jochen Talazko
Journal:  J Neurol       Date:  2005-01       Impact factor: 4.849

4.  Comparison of analytical platforms for cerebrospinal fluid measures of β-amyloid 1-42, total tau, and p-tau181 for identifying Alzheimer disease amyloid plaque pathology.

Authors:  Anne M Fagan; Leslie M Shaw; Chengjie Xiong; Hugo Vanderstichele; Mark A Mintun; John Q Trojanowski; Els Coart; John C Morris; David M Holtzman
Journal:  Arch Neurol       Date:  2011-05-09

5.  Cerebrospinal fluid levels of total-tau, phospho-tau and A beta 42 predicts development of Alzheimer's disease in patients with mild cognitive impairment.

Authors:  Niels Andreasen; Eugeen Vanmechelen; Hugo Vanderstichele; Pia Davidsson; Kaj Blennow
Journal:  Acta Neurol Scand Suppl       Date:  2003

6.  Amyloid-beta(1-42), total tau, and phosphorylated tau as cerebrospinal fluid biomarkers for the diagnosis of Alzheimer disease.

Authors:  Cees Mulder; Nicolaas A Verwey; Wiesje M van der Flier; Femke H Bouwman; Astrid Kok; Evert J van Elk; Philip Scheltens; Marinus A Blankenstein
Journal:  Clin Chem       Date:  2009-10-15       Impact factor: 8.327

7.  Progressive posterior cortical dysfunction: a clinicopathologic series.

Authors:  J A Renner; J M Burns; C E Hou; D W McKeel; M Storandt; J C Morris
Journal:  Neurology       Date:  2004-10-12       Impact factor: 9.910

8.  Posterior cortical atrophy: clinical characteristics and differences compared to Alzheimer's disease.

Authors:  Mario F Mendez; Mehdi Ghajarania; Kent M Perryman
Journal:  Dement Geriatr Cogn Disord       Date:  2002       Impact factor: 2.959

9.  Cognitive phenotypes in Alzheimer's disease and genetic risk.

Authors:  Julie S Snowden; Cheryl L Stopford; Camille L Julien; Jennifer C Thompson; Yvonne Davidson; Linda Gibbons; Antonia Pritchard; Corinne L Lendon; Anna M Richardson; Anoop Varma; David Neary; David Mann
Journal:  Cortex       Date:  2007-10       Impact factor: 4.027

10.  Visual field loss in senile dementia of the Alzheimer's type.

Authors:  G L Trick; L R Trick; P Morris; M Wolf
Journal:  Neurology       Date:  1995-01       Impact factor: 9.910
View more
  1 in total

1.  Posterior Type of Alzheimer's Dementia Presenting with Homonymous Hemianopsia.

Authors:  YoonAh Park; Kun-Woo Park; Chan-Nyeong Lee
Journal:  Dement Neurocogn Disord       Date:  2017-12-31
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.